local advanced colorectal cancer
Showing 1 - 25 of >10,000
Multiple Cancer, Colorectal Cancer Trial (MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 mAb neoadjuvant
Not yet recruiting
- Multiple Cancer
- Colorectal Cancer
- MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 monoclonal antibody neoadjuvant therapy
- All-MSI-H (dMMR) sMPCC: single-drug PD-1 monoclonal antibody neoadjuvant therapy
- (no location specified)
Aug 20, 2023
Colorectal Cancer, Adjuvant Chemo Trial in Guangzhou (wait and watch, adjuvant chemo)
Recruiting
- Colorectal Cancer
- Adjuvant Chemotherapy
- wait and watch
- adjuvant chemotherapy
-
Guangzhou, Guangdong, ChinaSixth Affiliated Hospital of Sun Yat-sen University
Jan 25, 2022
Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in Guangzhou (Neoadjuvant
Recruiting
- Colorectal Cancer
- +3 more
- Neoadjuvant therapy with PD-L1 inhibitor
-
Guangzhou, Guangdong, Chinathe Third Affiliated Hospital of Sun Yat-Sen University
May 10, 2022
Advanced Colorectal Cancer, Circulating Tumor DNA Trial in Shanghai (Local treatment)
Recruiting
- Advanced Colorectal Cancer
- Circulating Tumor DNA
- Local treatment
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 8, 2022
Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Microsatellite Stable Colorectal Cancer Trial in Worldwide
Recruiting
- Cervical Cancer
- +4 more
-
La Jolla, California
- +19 more
Jun 28, 2022
Colorectal Cancer, Immunotherapy Trial in Guangzhou (mFOLFOX6+Bevacizumab+PD-1 mAb treatment combinations)
Recruiting
- Colorectal Cancer
- Immunotherapy
- mFOLFOX6+Bevacizumab+PD-1 monoclonal antibody treatment combinations
-
Guangzhou, Guangdong, ChinaSun Yatsen University
May 19, 2021
Colorectal Cancer Metastatic Trial in Philadelphia (Local consolidative therapy)
Withdrawn
- Colorectal Cancer Metastatic
- Local consolidative therapy
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Dec 7, 2022
Locally Advanced Colorectal Cancer Trial (Capecitabine, Oxaliplatin, Bevacizumab)
Not yet recruiting
- Locally Advanced Colorectal Cancer
- Capecitabine
- +3 more
- (no location specified)
Oct 18, 2022
Advanced Colorectal Cancer Trial in Hangzhou (Cetuximab Dabrafenib Tislelizumab)
Not yet recruiting
- Advanced Colorectal Cancer
- Cetuximab Dabrafenib Tislelizumab
-
Hangzhou, Zhejing, ChinaZhejiang Cancer Institute & Hospital
Jul 19, 2023
Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H
Recruiting
- Colorectal Cancer
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 18, 2023
Colon Cancer, Neoadjuvant Therapy, Immunotherapy Trial in Guangzhou (Envafolimab, CAPEOX)
Recruiting
- Colon Cancer
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Aug 26, 2023
Advanced Colorectal Cancer Trial in Hangzhou (Fruquintinib Combined With Chemotherapy)
Not yet recruiting
- Advanced Colorectal Cancer
- Fruquintinib Combined With Chemotherapy
-
Hangzhou, Zhejing, ChinaZhejiang Cancer Institute & Hospital
Jun 29, 2023
Advanced Solid Tumors Trial in Worldwide (BMS-986466, Adagrasib, Cetuximab)
Not yet recruiting
- Advanced Solid Tumors
- BMS-986466
- +2 more
-
Birmingham, Alabama
- +24 more
Aug 29, 2023
Colorectal Cancer, Oligometastatic Disease Trial in Australia (Local Ablative Therapy, Standard first-line systemic treatment)
Recruiting
- Colorectal Cancer
- Oligometastatic Disease
- Local Ablative Therapy
- Standard first-line systemic treatment
-
Albury, New South Wales, Australia
- +8 more
May 15, 2023
HER2, Colorectal Cancer Trial (Disitamab Vedotin Combined With Fruquintinib)
Not yet recruiting
- HER2
- Colorectal Cancer
- Disitamab Vedotin Combined With Fruquintinib
- (no location specified)
Dec 21, 2022
Advanced Colorectal Carcinoma Trial in Beijing (palliative care group first-line scheme+compound kushen injection, palliative
Recruiting
- Advanced Colorectal Carcinoma
- palliative care group first-line scheme+compound kushen injection
- palliative care group first-line scheme
-
Beijing, ChinaGuang 'anmen Hospital, China Academy of Chinese Medical Sciences
Jun 7, 2023
Colorectal Cancer Trial in Tai'an (Tas-102(Suyuan) combined with bevacizumab)
Not yet recruiting
- Colorectal Cancer
- Tas-102(Suyuan) combined with bevacizumab
-
Tai'an, Shandong, ChinaThe Second Affiliated Hospital of Shandong First Medical Univers
Oct 14, 2023
Colorectal Cancer Trial in Durham (VR Blue)
Completed
- Colorectal Cancer
- VR Blue
-
Durham, North CarolinaDuke Cancer Institute
Jul 27, 2022
Colorectal Cancer Trial in Shanghai (FOLFIRI+Bevacizumab)
Recruiting
- Colorectal Cancer
-
Shanghai, Pudong, ChinaAffiliated Cancer Hospital of Fudan University
Jul 24, 2023
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and
Not yet recruiting
- Colorectal Neoplasms
-
Beijing, Xicheng Dis, ChinaBeijing Friendship Hospital, Capital medical University
Sep 5, 2023
Rectal Cancer Trial in Chongqing (CIETAI-R)
Recruiting
- Rectal Cancer
- CIETAI-R
-
Chongqing, Chongqing, ChinaDaping Hospital, Third Military Medical University
Jul 21, 2023
Test for Colorectal Cancer and Advanced Adenoma
Not yet recruiting
- Colorectal Cancer
- +3 more
- Mainz Biomed Colorectal Cancer Screening Test
- (no location specified)
Dec 6, 2022
Colorectal Cancer Trial in Taipei (Robotic surgery)
Recruiting
- Colorectal Cancer
- Robotic surgery
-
Taipei, TaiwanJin-Tung LIANG
Jul 27, 2023